Showing results (71-80 of 83) with videos related to
Sort By:
Pageof 9
Journal of Virology|October 29, 2010
A new model of Epstein-Barr virus infection reveals an important role for early lytic viral protein expression in the development of lymphomasShi-Dong Ma, Subramanya Hegde, Ken H Young, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 15, 2016
Lenalidomide, Thalidomide, and Pomalidomide Reactivate the Epstein-Barr Virus Lytic Cycle through Phosphoinositide 3-Kinase Signaling and Ikaros ExpressionRichard J Jones, Tawin Iempridee, Xiaobin Wang, et al.Mbio|August 22, 2019
Epstein-Barr Virus Infection Promotes Epithelial Cell Growth by Attenuating Differentiation-Dependent Exit from the Cell CycleMark R Eichelberg, Rene Welch, J Tod Guidry, et al.Plos Pathogens|June 17, 2020
EBNA2-deleted Epstein-Barr virus (EBV) isolate, P3HR1, causes Hodgkin-like lymphomas and diffuse large B cell lymphomas with type II and Wp-restricted latency types in humanized miceChunrong Li, James C Romero-Masters, Shane Huebner, et al.Plos Pathogens|July 28, 2018
A cancer-associated Epstein-Barr virus BZLF1 promoter variant enhances lytic infectionJillian A Bristol, Reza Djavadian, Emily R Albright, et al.Journal of Virology|March 6, 2020
An EBNA3A-Mutated Epstein-Barr Virus Retains the Capacity for Lymphomagenesis in a Cord Blood-Humanized Mouse ModelJames C Romero-Masters, Makoto Ohashi, Reza Djavadian, et al.Plos Pathogens|April 26, 2022
Reduced IRF4 expression promotes lytic phenotype in Type 2 EBV-infected B cellsJillian A Bristol, Joshua Brand, Makoto Ohashi, et al.Plos Pathogens|October 3, 2015
Differentiation-Dependent KLF4 Expression Promotes Lytic Epstein-Barr Virus Infection in Epithelial CellsDhananjay M Nawandar, Anqi Wang, Kathleen Makielski, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 11, 2018
Complete and Durable Responses in Primary Central Nervous System Posttransplant Lymphoproliferative Disorder with Zidovudine, Ganciclovir, Rituximab, and DexamethasoneJames P Dugan, Bradley M Haverkos, Lynda Villagomez, et al.Plos Pathogens|October 3, 2022
Type 1 and Type 2 Epstein-Barr viruses induce proliferation, and inhibit differentiation, in infected telomerase-immortalized normal oral keratinocytesDeo R Singh, Scott E Nelson, Abigail S Pawelski, et al.Pageof 9